Risk Factors for Endometrial Cancer among Women with a BRCA1 or BRCA2 Mutation: A Case Control Study

PURPOSE: BRCA mutation carriers may use tamoxifen for breast cancer prevention or treatment. Hormone replacement therapy is often prescribed after surgical menopause and oral contraceptives are recommended for ovarian cancer prevention. The objective of this study was to assess the impact of these m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Fam Cancer
Main Authors: Segev, Yakir, Rosen, Barry, Lubinski, Jan, Gronwald, Jacek, Lynch, Henry T., Moller, Pal, Kim-Sing, Charmaine, Ghadirian, Parviz, Karlan, Beth, Eng, Charis, Gilchrist, Dawna, Neuhausen, Susan L., Eisen, Andrea, Friedman, Eitan, Euhus, David, Ping, Sun, Narod, Steven A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4962606/
https://ncbi.nlm.nih.gov/pubmed/25838159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10689-015-9798-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados